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Case StudyAutoimmunity to Munc-18
in Rasmussen’s Encephalitis
tion of the involved hemisphere is the standard therapy
(Rasmussen and Andermann, 1989).
Recent discoveries implicate autoimmunity in the
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by protein A affinity chromatography of the serum sup-
ported a causal role for antibodies in particular (Antozzi
et al., 1998). The clinical improvement after removal ofSummary
serum IgG led to the suggestion that a defective blood–
brain barrier permitted access of these large proteinsRasmussen’s encephalitis (RE) is a rare disease of
(160 kDa) to their epitopes on neurons within the centralthe central nervous system characterized by severe
nervous system (Rogers et al., 1994). This suggestionepileptic seizures, progressive degeneration of a sin-
found support when anti-rabbit IgG immunohistochem-gle cerebral hemisphere, and autoimmunity directed
istry disclosed IgG-decorated cortical neurons in a sub-against glutamate receptor subunit, GluR3. We report
set of GluR3 immunized rabbits, which developed epi-here the identification of high-titer autoantibodies di-
leptic seizures but not in a subset of GluR3 immunizedrected against munc-18 in the serum of a single patient
rabbits that were otherwise healthy (He et al., 1998).with RE previously shown to have anti-GluR3 antibod-
Additional support emerged from immunocytochemicalies. Munc-18 is an intracellular protein residing in pre-
study of cortical tissue surgically removed from RE pa-synaptic terminals, which is required for secretion of
tients, which disclosed the presence of IgG immunore-neurotransmitters. These findings are consistent with
activity of soma and dendrites of cortical neurons in athe possibility of intermolecular epitope spreading be-
pericapillary distribution, consistent with access of IgGtween GluR3, a postsynaptic cell surface protein, and
from the systemic circulation (Whitney et al., 1999). Themunc-18, a presynaptic intracellular protein. Immune
event, which initiates the autoimmunity, has been postu-attack on these two proteins, which participate at dis-
lated to involve a microbial infection of a geneticallytinct steps of synaptic transmission, could act in an
susceptible host in which case molecular mimicry be-additive or synergistic manner to impair synaptic func-
tween the microorganism and self triggers autoimmunitytion and lead to seizures and neuronal death.
(Rogers et al., 1994). Autoimmunity to another glutamate
receptor, mGluR1, was recently identified in a para-Introduction
neoplastic syndrome (Sillevis Smitt et al., 2000).
The goal of the present work was to determineRasmussen’s encephalitis (RE) is a disease of childhood
whether additional proteins of excitatory synapses maycharacterized by progressive destruction of a single ce-
be targets of the immune system in RE.rebral hemisphere (Rasmussen et al., 1958). The disease
typically starts in the first decade of life and is mani-
Resultsfested by severe seizures and progressive loss of func-
tions subserved by the involved hemisphere. The histo-
Case Reportpathology consists of perivascular lymphocytic cuffing,
This 9-year-old right-handed white female was healthymicroglial nodules, neuronal destruction, and gliosis.
until age 6 when she sustained a minor injury to her leftBecause the epileptic seizures are typically unrespon-
forehead. She developed focal motor seizures 3 weekssive to antiseizure drugs, surgical removal or inactiva-
thereafter, involving her right body, some of which be-
came secondarily generalized tonic–clonic seizures.k To whom correspondence should be addressed (e-mail: jmc@neuro.
These seizures increased in frequency (12–20 per day)duke.edu).
despite a diversity of antiseizure medications. The pa-# Present address: Department of Neurology, Sydney Children’s
Hospital, High Street, Randwick NSW 2031, Australia. tient also developed a right hemiparesis, a language
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disturbance, and cognitive decline. Magnetic resonance
imaging disclosed progressive atrophy of the left hemi-
sphere. A brain biopsy performed at age 7 disclosed
findings consistent with Rasmussen’s encephalitis.
Neurological examination disclosed a right hemiparesis
with right-sided hyperreflexia, neglect of visual stimuli
in the right visual field, a right-sided hemisensory loss,
and an expressive dysphasia. GluR3 immunoreactivity,
monitored with an enzyme-linked immunoabsorbent
assay (ELISA), was high. She was treated with recurrent,
single-volume plasma exchange (PEX) and exhibited
striking improvement beginning within 5 days of initiat-
ing therapy. During the first 7 weeks of PEX, seizure
frequency decreased by 80%. Cognition, speech, and
hemiparesis improved, correlating in time with dimin-
ished GluR3 immunoreactivity. Over the ensuing 4
weeks, however, seizure frequency increased, and cog-
nition, speech, and motor skills deteriorated in parallel
with increased GluR3 immunoreactivity. Repeated se-
ries of PEX (five exchanges per series) produced similar
transient improvements persisting for 4–9 weeks, but
the degree of improvement decreased in subsequent
trials. She underwent a left hemispherectomy at another
institution at age 11, developed a worsening of her lan-
guage function, and has been lost to follow-up. More
extensive details of her case are presented in previous
reports (Rogers et al., 1994; Andrews et al., 1996 [patient
#1]). Plasma removed during the initial series of plasma
exchange demonstrated the presence of GluR3 antibod-
ies (Rogers et al., 1994) and was used in experiments
of the present report.
Figure 1. Autoantibodies of RE Patient Recognize a Protein with an
Autoantibodies of RE Patient Recognize a Protein Apparent Electrophoretic Mobility of 71 kDa that Is Enriched in Rat
with an Apparent Electrophoretic Mobility Brain Synaptosomes
of Approximately 71 kDa (A and B) Western blot analyses of rat brain and liver extracts were
To identify proteins other than GluR3 targeted by anti- separated on SDS-PAGE and immunoblotted with RE patient serum
(A) and control human serum (B). Lane 1, P2 brain extract; lane 2,bodies in RE, subcellular fractions were prepared from
P2 liver extract; lane 3, triton extract of P2 (brain); lane 4, tritonrat brain and liver, subjected to SDS-PAGE, electro-
extract of P2 (liver). RE patient’s serum recognizes an autoantigentransferred to a membrane, and probed with plasma
from brain extracts but not liver extracts. Control human serumfrom the RE patient whose case is described in the
failed to recognize any proteins. The same amount of protein (40
preceding paragraph. A prominent band of apparent mg) protein was loaded in all lanes. (A) and (B) represent two different
electrophoretic mobility of approximately 71 kDa was blots; after probing the blot in (B) with control serum, the blot was
stripped and reprobed with RE patient’s serum and results equiva-detected in the P2 fraction and the triton X-100 extract
lent to that of (A) were obtained (data not shown).of P2 isolated from brain but not liver (Figure 1A). A minor
(C) Rat cerebral cortex and hippocampus were fractionated as de-band of higher electrophoretic mobility was detected in
scribed in Experimental Procedures. Equal amounts (10 mg of pro-the liver fractions. The autoantigen detected in the brain
tein) from crude homogenate (lane 1), P2 fraction (lane 2), cytosol
fractions was specific for the RE serum as a control (lane 3), and synaptosomes (lane 4) were separated by SDS-PAGE,
human serum failed to detect the p71 autoantigen (Fig- electrotransferred, and immunoblotted with RE patient’s serum. p71
is recognized in the crude homogenate, P2 fraction, and the synap-ure 1B) and the secondary anti-human antibody alone
tosomal fraction (lanes 1, 2, and 4), but not in the cytosolic fractiondid not detect any proteins on the immunoblot (data
(lane 3). The synaptosomal fraction was enriched in this autoantigennot shown). Additional fractionation of rat cortex and
as judged by the intensity of the band. Asterisk denotes p71.hippocampus was performed to determine a source en-
riched in p71. The P2 fraction was further separated by
discontinuous sucrose gradient centrifugation and the fraction was subjected to sequential chromatography
synaptosomal fraction was found to be enriched in p71 on CM cellulose and DEAE cellulose, followed by size
as judged by the relative intensities of the bands in fractionation on a Sephadex G-100 column. The en-
various fractions (Figure 1C). riched fractions following ion exchange chromatogra-
phy were pooled and applied to Sephadex G-100 and
further separated (Figure 2A); fractions #52, 56, and 60Purification and Molecular Identification of p71
The relative enrichment of p71 in the synaptosomal frac- of the Sephadex G-100 column (Figure 2A) were run on
two identical preparative SDS-polyacrylamide gels. Onetion and the ease of detection of the autoantigen on
an immunoblot provided an opportunity to identify the gel was electrotransferred to a membrane and immu-
noblotted using RE patient sera, and subsequently theprotein. To purify p71, the solubilized synaptosomal
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Figure 2. Purification and Protein Sequenc-
ing of p71
(A) Sephadex G-100 column purification step.
Aliquots (40 ml) of 1 ml Sephadex G-100 col-
umn fractions as indicated were separated
on SDS-PAGE gel and immunoblotted with
RE patient serum. The distribution of p71 in
the Sephadex G-100 column chromatogra-
phy is shown; the size of p71 as determined
by size standards (Amersham Pharmacia)
was calculated to be approximately 69 kDa.
(B) Colloidal Coomassie blue staining of
Sephadex G-100 fractions discloses two
bands; 75 ml each of three fractions (#52, 56,
60) were separated by preparative SDS-
PAGE and stained with colloidal Coomassie
blue (Owl Sci.) as recommended by the sup-
plier. An identical gel was run and immuno-
probed with RE patient serum (data not
shown); the immunoreactivity overlaid with
colloidal Coomassie blue–stained bands la-
beled as upper band and lower band.
(C) Protein sequencing of p71 by LC/MS/MS.
The upper and lower bands from the fractions
shown in (C) of Sephadex G-100 column were
excised separately and were pooled as upper
and lower bands, respectively. Tryptic diges-
tion of the gel fragments containing the upper
and lower bands, respectively, was carried
out followed by protein sequencing by LC/
MS/MS as described in Experimental Proce-
dures. Figure shows sequence coverage of
munc-18 from such an analysis. Product ion spectra for the peptides shown in red matched with munc-18 when searched against the
nonredundant protein database using the Mascot search program. The upper and lower bands yielded identical peptide sequences. The
peptide sequences shown in red were the only sequences obtained, thereby arguing against a comigrating protein.
membrane underwent silver staining; the other gel was to a membrane, and probed with the patient’s serum
(data not shown). The use of the larger sized preparativestained with colloidal Coomassie blue. When the immu-
noblot and the silver-stained membrane were overlaid gels permitted distinction of the two proteins, whereas
the proteins appeared to run as a single band in minigelsusing the molecular weight standards as references, the
immunodetected bands overlaid an intensely stained as shown in Figures 1, 2A, and 3. The proteins desig-
nated rbSec1A and rbSec1B correspond to munc-18-band on the silver-stained membrane. Comparison with
the colloidal Coomassie-stained gel detected two bands 1a and munc-18-1b, respectively (Gengyo-Ando et al.,
1996). The proteins will subsequently be referred to col-with electrophoretic mobility similar to the immunoreac-
tivity (Figure 2B); each of the two bands was excised lectively as munc-18.
from the gel and subjected to tryptic digestion and pro-
tein sequencing by liquid chromatography/mass spec- Evidence that the Autoantigen Detected
by RE Serum Is Munc-18trometry/mass spectrometry (LC/MS/MS). Product ion
spectra for the peptides obtained from these analyses To confirm that the protein recognized by the RE serum
was indeed munc-18, four experimental approachesdisclosed identical peptide sequences for the upper and
lower bands (see red letters in Figure 2C); comparison were taken. First, synaptosomal fractions were sepa-
rated by SDS-PAGE, electrotransferred, blotted, andof these sequences with the nonredundant protein data-
base using the Mascot search program (Perkins et al., probed with RE serum or an affinity-purified anti-munc-
18 antibody; the bands recognized by each were found1999) disclosed that these peptides were almost cer-
tainly isolated from a protein known by three different to have equivalent electrophoretic mobility and distribu-
tion (data not shown). Second, the Sephadex G-100names, munc-18-1 (Hata et al., 1993), nSec-1 (Pevsner
et al., 1994), and rbSec1A (Garcia et al., 1994). This column size fractionated samples were electrophoresed
on two identical polyacrylamide gels, electrotransferredprotein consists of 594 amino acids (67.5 kDa); an iso-
form in which 110 base pairs are inserted at position to membranes, and probed with either anti-munc-18 or
RE patient serum (Figure 3A). Anti-munc-18 antibody11702 of rbSec1A mRNA encodes a protein of 603
amino acids (68.4 kDa, rbSec1B) (Garcia et al., 1995). and RE patient serum recognized a single major band
of identical electrophoretic mobility; there was similarityThe patient’s antibodies recognized both rbSec1A and
rbSec1B (lower and upper bands of Figure 2B) as evident in the presence or absence as well as relative intensity
of immunoreactivity in the lanes (Figure 3A). Third, onein experiments in which the two proteins were separated
by SDS-PAGE, stained with colloidal Coomassie blue, of the fractions from the Sephadex G-100 (#54) was
subjected to immunoprecipitation with the munc-18 oreluted individually, loaded in separate lanes of an addi-
tional gel, separated by SDS-PAGE, electrotransferred a control (anti-NMDAR1) antibody, and the resulting
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fractions were probed with anti-munc-18 or RE patient
serum. Munc-18 was immunoprecipitated by the anti-
munc-18 (Figure 3B, lane 3, upper panel) but not the
anti-NMDAR1 antibody (lane 5, upper panel) as evident
in the various fractions probed with the anti-munc-18
antibody; probing aliquots of these same fractions with
the RE serum disclosed that the RE serum recognized
the immunoprecipitated munc-18. The small amount of
immunoreactivity in lanes 5 and 7 (upper panel) reflect
nonspecific binding of the munc-18 to the beads. Fourth,
to determine whether IgG of the RE serum recognized
recombinant rat munc-18, the following experiments
were performed. Rat munc-18 was cloned into a
pcDNA3 vector (InVitrogen) with a His tag on either the
C or N terminus and expressed in HEK 293 cells. Lysates
of the HEK 293 cells were subjected to SDS-PAGE and
subsequent immunoblotting. Munc-18 was recognized
by anti-munc-18 antibodies and RE patient serum (lanes
1 and 2, upper and lower panels, respectively, of Figure
3C). By contrast, no immunoreactivity was detected in
293 cells transfected with pcDNA3 containing the cDNA
for the complement regulatory protein, Crry (lane 3) nor
in mock transfected HEK cells (lane 5) or other controls
(lanes 4 and 6). Together, this evidence demonstrates
that the immunoreactive band in the synaptosomes de-
tected by the antibodies in the RE serum is munc-18.
Further Analyses of Immunoreactivity to Munc-18
in Rasmussen’s Encephalitis
To examine the presence of antibodies to munc-18 in the
Figure 3. Evidence that Autoantigen Is Munc-18 sera of additional individuals, the following experiments
(A) Munc-18 antibody and autoantibodies of RE patient recognize were performed. Immunoblots were prepared following
the same band in Sephadex G-100 column fractions. Sephadex SDS-PAGE and were probed with sera from 14 patients
G-100 fractions (40 ml) from various fractions were separated on with clinical and neuropathological evidence of RE, ten
two identical gels and immunoblotted with munc-18 antibody or RE healthy controls, five patients with diverse inflammatory
patient serum. Munc-18 antibody and RE patient serum recognized
or immune abnormalities (tuberculous meningitis, throm-the same size molecule (and presumably the same protein) and
botic thrombocytopenic purpura, myasthenia gravis,exhibited a similar distribution for the presence and absence and
relative intensity of the immunoreactivity. Upper panel was probed Guillain Barre syndrome, multiple myeloma), and nine
with munc-18 antibody, and the lower panel was probed with RE patients with epilepsy not due to RE; the blots were
patient serum. Asterisk refers to munc-18. interpreted by an observer (J. O. M.) blinded to affected
(B) RE patient serum recognizes immunoprecipitated munc-18. status of patients. To examine immunoreactivity to na-
Sephadex G-100 fraction (#54) was immunoprecipitated with anti-
tive munc-18, munc-18 was partially purified from ratmunc-18 (3 mg) or anti- NR1 (3 mg) (control) antibodies coupled to
brain; fractions obtained following Sephadex G-100protein G (100 ml), and the bound and unbound fractions were
probed with either anti-munc-18 (top row) or RE serum (bottom chromatography (like that shown in Figure 3B) were sub-
row). Lane 1, Sephadex G-100 fraction (starting material); lane 2, jected to immunoprecipitation with an anti-munc-18 an-
supernatant from anti-munc-18 (unbound); lane 3, beads coated tibody. The starting material, supernatant, and immuno-
with anti-munc-18 antibody (bound); lanes 4 and 5 show the super- precipitated material were separated by SDS-PAGE and
natant (unbound) and beads (bound) using anti-NR1 as control.
probed with sera diluted 1:300 (data not shown). ToLanes 6 and 7 show unbound and bound fractions, respectively, in
examine immunoreactivity to recombinant munc-18, re-absence of any antibody. The upper panel was probed with anti-
munc-18, and the lower panel was probed with RE serum. Both combinant munc-18 with a His tag on the N terminus
anti-munc-18 and RE serum detect a 71 kDa band that is selectively and a control His-tagged protein, sulfite oxidase, were
immunoprecipitated by anti-munc-18. Asterisk refers to antigen mi- subjected to SDS-PAGE, and immunoblots were pre-
grating at approximately 71 kDa. pared and probed with sera diluted 1:300. Similar re-
(C) Munc-18 antibody and RE serum recognize rat munc-18 ex-
sults were obtained with experiments using both nativepressed in human embryonic kidney (HEK) 293 cells. Rat munc-18
and recombinant munc-18. Intense immunoreactivity towas cloned in pcDNA3 with either C- or N-terminal 63 His tag and
transfected using calcium phosphate into HEK cells. Controls included munc-18 was consistently observed only in the RE pa-
HEK cells transfected with recombinant Crry cloned in pcDNA3 (lane tient whose sera was used for the purification (Figure
3); pcDNA3 without an insert (lane 4); treated with transfection buffer 4A). Weak immunoreactivity to munc-18 was observed
(lane 5); and untreated HEK cells (lane 6). C-terminal 63 His tag munc- with both native and recombinant munc-18 in each ex-
18 (lane 1) and N-terminal 63 His Tag munc-18 (lane 2) were the only
periment with longer exposures of the immunoblots inlanes where immunoreactive bands were seen with anti-munc-18 and
an additional patient with RE (data not shown) and inRE serum. Lane 7 shows synaptosomal extract as a positive control.
Both munc-18 antibody and RE patient serum recognize the munc- one healthy control (Figure 4A); however, in an earlier
18 band. Asterisk refers to munc-18. experiment (see control in Figure 1A), no immunoreactiv-
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Figure 4. Analyses of Immunoreactivity to Munc-18 in Rasmussen’s Encephalitis
(A) Immunoblot discloses intense immunoreactivity to recombinant munc-18 with serum of single RE patient. Two proteins with a His tag,
munc-18 or sulfite oxidase, were subjected to SDS-PAGE and immunoblots prepared and probed with 1:300 dilution of serum of RE patient
(left blot) or a healthy control (right blot). Faint immunoreactivity to munc-18 is present with healthy control serum in comparison to intense
immunoreactivity to munc-18 (denoted by asterisk) with RE patient serum used for purification of munc-18. No immunoreactivity to sulfite
oxidase was detected with serum from either patient. To control for loading and transfer of both proteins, the presence of the proteins was
verified by staining with Coomassie blue (data not shown).
(B) Anti-munc-18 IgG is present in cerebrospinal fluid (csf) of RE patient. Recombinant munc-18 was subjected to SDS-PAGE, and immunoblots
were prepared and probed with various dilutions of serum (1:10,000, 1:30,000, 1:60,000) or cerebrospinal fluid (1:50). Immunoreactivity to
munc-18 was detected in the cerebrospinal fluid and corresponded in intensity to dilutions of serum between 1:10,000 and 1:30,000. Asterisk
refers to munc-18.
(C) The concentration of anti-munc-18 antibodies in serum diminishes following plasma exchange. Recombinant munc-18 (denoted by asterisks)
was subjected to SDS-PAGE, and immunoblots were prepared and probed with serum (1:300) isolated prior to the first plasma exchange
(pre-PEX 1) or prior to subsequent plasma exchanges (pre-PEX 5, 10, 11, 13) performed at various intervals over a period of approximately
2 months. Reduction of the antibody concentrations is evident in the reduction of the intensity of immunoreactivity during the series of plasma
exchanges. Asterisk refers to munc-18.
ity to munc-18 was detected in the serum of the healthy side the central nervous system and gains access to the
central nervous system through the blood–brain barrier.control shown in Figure 4A. Weak immunoreactivity was
found in some, but not all, experiments in two additional Since this patient exhibited striking clinical improve-
ment following plasma exchange, it was of interest topatients with RE, one patient with epilepsy not due to
RE, and one healthy control. No immunoreactivity was determine whether the concentration of anti-munc-18
antibodies in serum diminished in association with clini-detected in sera from the remaining individuals.
To further examine the potential significance of the cal improvement. Recombinant munc-18 with a His tag
on the N terminus was subjected to SDS-PAGE, andmunc-18 immunoreactivity in the single positive RE pa-
tient, additional experiments were performed. Because immunoblots were prepared and probed with serum
(1:300) isolated prior to and at multiple points during athe anti-munc-18 antibody must gain access to its anti-
gen in the central nervous system to exert a biologi- series of plasma exchanges (Figure 4C). Reductions of
anti-munc-18 immunoreactivity were evident and corre-cal effect, the spinal fluid of the affected patient was
examined for anti-munc-18 antibodies. Recombinant lated with improvement in the patient’s clinical condition
during this series of plasma exchanges.munc-18 with a His tag on the N terminus and a control
His-tagged protein, sulfite oxidase, were subjected to
SDS-PAGE, and immunoblots were prepared and probed Discussion
with spinal fluid (1:50) and various dilutions of serum.
Immunoreactivity to munc-18 was detected in the spinal Our data demonstrate the presence of high titer serum
fluid and corresponded in intensity to dilutions of serum autoantibodies against a synaptic protein, munc-18, in
between 1:10,000 and 1:30,000 (Figure 4B); no immuno- a patient with RE previously shown to have antibodies
reactivity to sulfite oxidase was evident with either se- to a distinct synaptic protein, GluR3. The identification
rum or spinal fluid (data not shown). If the anti-munc-18 of serum autoantibodies to munc-18 relied upon the
IgG were synthesized within the central nervous system, readily detectable immunoreactivity to a synaptosomal
the concentration of anti-munc-18 IgG in the spinal fluid protein evident in immunoblots of rat brain extract. This
should exceed that of the serum when expressed per approach stands in sharp contrast to our previous dis-
amount of IgG. The concentration of IgG was determined covery of GluR3 autoantibodies in which the serendipi-
to be 0.481 and 95.5 mg/ml in the spinal fluid and serum, tous occurrence of a Rasmussen’s encephalitis-like ill-
respectively. If the concentration of anti-munc-18 IgG/ ness in rabbits immunized with recombinant GluR3
total IgG were equivalent in spinal fluid and serum, the peptide led to an intensive search for GluR3 antibodies;
immunoreactivity present with a 1:50 dilution of spinal this search detected serum GluR3 antibodies in serum
fluid should correspond to a dilution of serum of 1:9,920; of RE patients when using immunocytochemistry of
the fact that the immunoreactivity detected with a 1:50 transfected HEK 293 cells or immunoblots using large
dilution of spinal fluid was less than a serum dilution of amounts of GluR3 fusion proteins but not with the
1:10,000 indicates that the anti-munc-18 IgG is not being amounts of GluR3 present in rat brain extract (Rogers
synthesized with the central nervous system. Instead, et al., 1994).
The Sec1 family of proteins, of which munc-18 is athe anti-munc-18 is presumably being synthesized out-
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member, has been implicated in diverse secretory pro- raised in response to one of these proteins do not simply
cross-react with the other. “Intermolecular epitopecesses in organisms ranging from yeast to mammals
(Halachmi and Lev, 1996). Munc-18 is the mammalian spreading” provides a plausible explanation for the
presence of the munc-18 immunoreactivity; this refershomolog of yeast Sec1, C. elegans Unc-18, and Dro-
sophila Rop (Hata et al., 1993; Garcia et al., 1994; Pevs- to a process whereby antigen-specific autoimmune re-
sponses can spread to epitopes on other proteins presentner et al., 1994). Munc-18 is a cytosolic protein, which
is expressed in neurons throughout the central nervous in tissue damaged at the site of the disease (Vanderlugt
and Miller, 1996). This process has been characterizedsystem but not in other tissues. Munc-18 binds a diver-
sity of proteins including syntaxin 1A, mint 1 and 2, in other autoimmune diseases such as experimental al-
lergic encephalomyelitis (EAE) and multiple sclerosisdoc2a and doc2b, and cyclin-dependent kinase 5 (Hata
et al., 1993; Shetty et al., 1995; Okamoto and Sudhoff, (Tuohy et al., 1999). Initiation of EAE by immunization
with proteolipid protein (PLP) results in an immune re-1997; Verhage et al., 1997). The involvement of Sec1
family members in membrane fusion and secretion to- sponse initially targeting PLP but subsequently spread-
ing to other myelin antigens such as myelin oligodendro-gether with the interaction of munc-18 with syntaxin 1A
and its localization within presynaptic terminals sug- cyte protein and myelin basic protein (Tuohy et al., 1999).
Interestingly, in EAE and MS, reactivity to the initiatinggested a pivotal role in exocytotic secretion of neu-
rotransmitter. Wu et al. (1998) combined genetic ma- antigen diminishes as a new set of immune reactivities
emerges (Tuohy et al., 1999). These findings imply thatnipulations with electrophysiological analyses of the
Drosophila neuromuscular junction to demonstrate that the point in time in the course of the disease that a
patient or animal is studied will determine the particularthe munc-18 homolog, ROP, is both required and rate
limiting for evoked and spontaneous exocytosis. Dele- immunoreactivities identified. In the present patient, it is
not clear whether immunoreactivity to GluR3 antedatedtion of munc-18 in mouse by homologous recombination
produced a complete loss of neurotransmitter secretion munc-18 or vice versa, but it seems more likely that the
immune attack on GluR3 precedes that on munc-18 forfrom synaptic vesicles and lethality at birth, probably
due to inability to breathe (Verhage et al., 2000). In con- two reasons. One is that the locale of GluR3 on the
surface of the postsynaptic membrane simplifies acces-trast to the intracellular locale of munc-18, GluR3 resides
in the synaptic membrane and is part of a heteromeric sibility to humoral immune attack in comparison to the
cytosolic locale of munc-18. Another is that the anatomicAMPA receptor that binds synaptically released gluta-
mate and transduces this signal into depolarization of distribution of the pathology of RE, involving mainly neo-
cortex and archicortex correlates with the expressionthe postsynaptic neuron (Boulter et al., 1990; Keinanen
et al., 1990). While the majority of munc-18 and GluR3 of GluR3, whereas munc-18 is expressed in neurons
throughout the central nervous system. Thus, it seemsreside in presynaptic and postsynaptic locales, respec-
tively, the existence of AMPA receptors on presynaptic plausible that a humoral immune attack on GluR3 on
the surface of the postsynaptic membrane initiates de-terminals of GABAergic interneurons in the cerebellum
was recently reported (Satake et al., 2000). Moreover, struction of synapses that might then lead to exposure
of intracellular proteins such as munc-18 to cells ex-the fact that proteins such as NSF were initially impli-
cated in secretion of neurotransmitters and only later pressing class II MHC and subsequent presentation of
munc-18 peptides to CD41 T cells and expansion of anfound to be part of the molecular machinery underlying
cycling of AMPA receptors between intracellular vesi- immune attack. Our findings further suggest that immun-
ities to additional synaptic proteins will be found. Se-cles and synaptic membrane (Nishimune et al., 1998)
raises the interesting possibility that munc-18 might also quential study of these immunoreactivities in animal
models and humans with RE will be needed to clarifyparticipate in AMPA receptor cycling to the postsynaptic
membrane. Regardless of the potential of additional the antigen(s) that triggered the autoimmune response
and the temporal sequence of subsequent immunoreac-sites of these proteins, the presence of munc-18 and
GluR3 in presynaptic and postsynaptic locales respec- tivities.
Might autoantibodies to a cytosolic protein such astively implies that the immune system is targeting two
proteins involved in spatially and functionally distinct munc-18 contribute to the phenotype of RE? The pres-
ence of high titer anti-munc-18 in the serum and theaspects of the same process, namely synaptic trans-
mission, in this patient. The findings in this patient are presence of anti-munc-18 in the spinal fluid suggest that
these antibodies might contribute to the phenotype ofreminiscent of the recent observation in stiff person
syndrome (SPS), an autoimmune disorder affecting in- RE in this patient. The temporal correlation of plasma
exchange-induced clinical benefit and reductions of se-hibitory synapses in the spinal cord (Butler et al., 2000).
Autoantibodies to glutamic acid decarboxylase, a pre- rum anti-munc-18 suggest that anti-munc-18 might
somehow reversibly impair neuronal function, perhapssynaptic protein, have been identified in many patients
with SPS; recently, autoantibodies targeting gephryin, by interfering with synaptic transmission. Might anti-
munc-18 IgG undergo endocytosis, bind munc-18, anda cytosolic protein concentrated at the postsynaptic
membrane of inhibitory synapses, were identified in a interfere with secretion of neurotransmitter? While pos-
sible, accessibility of IgG to an intracellular target seemspatient with SPS who lacked autoantibodies to glutamic
acid decarboxylase (Butler et al., 2000). problematic. It seems more likely that anti-GluR3 IgG
can access its target on the extracellular surface of thePrecisely when and how the anti-munc-18 IgG
emerged in the sequence of immune reactivities of the neuron and compromise synaptic function either directly
(Twyman et al., 1995) or indirectly through activation ofpatient in the present report is uncertain. The absence
of detectable homology in the primary amino acid se- the complement cascade (He et al., 1998). Alternatively,
perhaps the anti-munc-18 IgG itself is not functioningquence of munc-18 and GluR3 suggests that antibodies
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20 min and dialyzed against at least 25 vol of 50 mM Tris-HCl (pHas an immune effector but rather reflects an immune
8.0), containing 0.1% Triton X-100, 10% glycerol, and 0.1 mM PMSFattack on munc-18 in which the key effector involves
with three to four changes over a 16 hr period; this fraction willcell mediated immune mechanisms as recently sug-
be referred to as synaptosomal extract. Protein concentration was
gested for autoimmunity to cdr-2 in paraneoplastic cere- estimated by Bradford method with Coomassie Plus Protein Assay
bellar degeneration (Albert et al., 1998). The presence Reagent (Pierce, Rockford, Illinois)
of CD81 T cells in a subset of RE brains (Whitney et al.,
1999) together with the restricted clonality of infiltrating Purification of p71 from Synaptosomal Extract
Sequential column chromatography was carried out using carboxy-T lymphocytes in RE brains (Li et al., 1997) is consistent
methyl cellulose (CM), diethylaminoethyl cellulose (DEAE), andwith this idea. The discovery that seizures can increase
Sephadex G-100 (Amersham Pharmacia, Uppsala, Sweden). Follow-expression of class I MHC in neurons (Corriveau et al.,
ing equilibration with 50 mM Tris-HCl (pH 8.0), 0.1% Triton X-100,
1998) raises the possibility that severe focal epileptic 10% glycerol, and 0.1 mM PMSF, 40 mg of synaptosomal extract
seizures occurring in RE upregulates class I MHC ex- protein in 20 ml was loaded to the CM column (50 ml). After washing
pression in neurons residing in the cortex exhibiting with 2 column volumes of equilibration buffer, the proteins were
eluted using 800 ml linear gradient of NaCl from 0.0–0.8 M in equili-frequent seizure activity. The increased expression of
bration buffer. The CM cellulose fractions were probed by immu-class I MHC in the “seizing” neurons might lead to their
noblots using the patient’s serum, and positive fractions werepresentation of processed munc-18 peptides to sensi-
pooled, dialyzed against at least 25 vol of 50 mM Tris-HCl (pH 8.0),
tized CD81 T cells and thereby target the “seizing” neu- 0.1% Triton X-100, 10% glycerol, and 0.1 mM PMSF, and loaded
rons for attack, cytolysis, and death. on a DEAE column (6 ml) preequilibrated with 50 mM Tris-HCl (pH
In conclusion, the identification of munc-18 as an au- 8.0), 0.1% Triton X-100, 10% glycerol, and 0.1 mM PMSF. After
washing with 2 column volumes of equilibration buffer, p71 wastoantigen in this patient with RE provides additional evi-
eluted with a linear gradient of NaCl from 0.0–0.8 M in equilibrationdence that RE can be associated with an immune attack
buffer. The DEAE cellulose fractions were probed by immunoblotson synaptic antigens. The precise role of autoantibodies
using the patient’s serum, and positive fractions were pooled and
to cytosolic proteins such as munc-18 in the pathogene- concentrated by cold acetone precipitation. The acetone pellet was
sis of RE requires further study. Analyses of a larger resuspended in equilibration buffer, and an aliquot was chromato-
series of RE patients at multiple times during their illness graphed on a Sephadex G-100 column equilibrated with 50 mM Tris-
HCl (pH 8.0), 0.1% Triton X-100, 10% glycerol, and 0.1 mM PMSF.with a highly sensitive assay may disclose additional
Fractions were probed by immunoblots using the patient’s serum.RE patients with anti-munc-18 antibodies. In any case,
immune attack on two proteins, GluR3 and munc-18,
SDS-PAGE and Western Blot Analysisthat function at distinct steps of the complex coordi-
SDS-PAGE electrophoresis was carried out by standard procedure
nated task of synaptic transmission could act in an addi- (Laemmli, 1970). Western blot analysis was carried out using PVDF
tive or synergistic manner to impair synaptic function membrane (Millipore, Bedford, MA) as recommended by manufac-
and lead to seizures and neuronal death in the present turer. Briefly, approximately 10–60 mg of rat brain or synaptosomal
extract was electrotransferred on a 8.5% or 10% SDS-polyacryl-patient.
amide gel, electroblotted onto PVDF membrane, blocked with 5%
non-fat milk in 13 phosphate-buffered saline containing 0.1%Experimental Procedures
Tween 20, and probed with antibody or serum at appropriate dilu-
tion. To detect the immunoreactive bands in purification steps, 40Rat Brain and Liver Extracts
ml of fractions from CM, DEAE cellulose, or Sephadex G-100 wereCortex and hippocampus were dissected from adult male Sprague-
used. RE patient and control serum were used at 1:200 dilution.Dawley rats (250–300 g) and homogenized in 10 vol 0.32 M sucrose–1
Peptide affinity-purified rabbit anti-munc-18 antibody (Affinity Biore-mM Tris (pH 7.4) with ten strokes in a glass-Teflon homogenizer at
agents, Golden, CO) was used at 0.5 mg/ml. Secondary antibody800 rpm; this preparation is referred to as the crude brain homoge-
(Amersham) is HRP conjugated and used at 1:5000 dilution. Thenate. In other experiments, liver was removed and subjected to
anti-NMDAR1 antibody was raised by immunization of rabbits withsimilar homogenization. Following centrifugation at 500 3 g for 15
a peptide in the C terminus and was affinity purified (Chemicon,min, the supernatant was removed and subjected to centrifugation
Temecula, CA). The immunoblots were developed with enhancedat 14,500 3 g for 20 min, providing a crude mitochondrial pellet
chemiluminescence (Amersham Pharmacia, Buckinghamshire, United(P2); the supernatant was centrifuged at 43,500 3 g for 100 min,
Kingdom). Conventional Coomassie blue, colloidal Coomassie blueand the resulting supernatant is referred to as cytosol. The crude
staining (OwlSci, Portsmouth, NH) on gel, and colloidal silver stain-mitochondrial pellet was washed twice with 0.32 M sucrose–1 mM
ing on membrane were used for detecting proteins.Tris (pH 7.4), pelleted by centrifugation at 14,500 3 g for 20 min,
and solubilized in 0.5 M KHPO4 (pH 7.0), 20% glycerol, 0.1 mM
PMSF, 1% Triton X-100, and 1 mM EGTA at room temperature Identification of p71 by Liquid Chromatography/Mass
Spectrometry/Mass Spectrometrywith constant agitation for 30 min. The soluble protein fraction was
obtained by centrifugation at 14,500 3 g for 20 min and dialyzed The bands of interest were excised from the 1D gel and digested
in-gel with trypsin (Boehringer Mannheim, Indianapolis, IN) in 10against at least 25 vol of 50 mM Tris-HCl (pH 8.0), containing 0.1%
Triton X-100, 10% glycerol, and 0.1 mM PMSF with three to four mM Tris (pH 8.0), according to the procedure of Shevchenko et al.
(1996) except that alkylation of sylfhydryls was accomplished withchanges over a 16 hr period (Triton extract of P2).
In other experiments, synaptosomes were purified from a crude 4-vinylpyridine. Following incubation at 378C for 16 hr, digests were
vortexed and placed in a sonication bath for 5 min. The liquid aroundmitochondrial pellet of rat brain (P2). P2 was washed twice with
0.32 M sucrose–1 mM Tris (pH 7.4), resuspended in the same buffer, the gel pieces was removed and saved. The gel pieces were then
extracted with a second aliquot of 10 mM Tris that was pooled withlayered over equal volumes of 0.76 M and 1.2 M sucrose-1 mM Tris-
HCl (pH 7.4), and spun in a Beckman ultracentrifuge sw28 swinging the extracts. Finally, the gel pieces were extracted with acetonitrile,
which was combined with the other extracts. Volume and organicbucket rotor at 53,000 3 g for 1 hr. The synaptosomes were isolated
from the 0.76–1.2 M interface. Following addition of 1.5 vol of 1 content in the in-gel digest extract was reduced by concentration
in a Speed Vac (approximately 60 ml final volume). Liquid chromatog-mM Tris (pH 7.4), synaptosomes were pelleted by centrifugation at
14,500 3 g for 20 min and solubilized in 30 ml of 0.5M KHPO4 (pH raphy/mass spectrometric analysis of digests was done using an
Ultimate capillary LC system (LC Packings, San Francisco, CA)7.0), 20% glycerol, 0.1 mM PMSF, 1% Triton X-100, and 1mM EGTA
at room temperature with constant agitation for 30 min. The soluble (equipped with a Famos autosampler) coupled to a quadropole time-
of-flight (Q-TOF) mass spectrometer (Micromass, Manchester, UK)protein fraction was obtained by centrifugation at 14,500 3 g for
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equipped with a Z-spray ion source. Digests were preconcentrated TCGG-39 (SphI restriction site shown in italics); (2) reverse primer,
59-ATAGTCAAGCTTACTGCTTATTTCTTCGTCTGTTTTATTCAGCT-39and desalted onto a 300 mm id 3 1 mm guard column (LC Packings)
packed with Pepmap C 18 material using the Famos autosampler. (HindIII restriction site shown in italics). Cloning was performed at
SphI, HindIII sites in pQE 80L. Propagation of host cells, expressionAfter the preconcentration step, the guard column was switched in-
line with the analytical capillary column. Peptides were then sepa- of the proteins in bacteria, and purification of the 63 His-tagged
proteins with Nickel-NTA agarose were carried out as suggestedrated using a 75 mm id 3 15 cm capillary packed with 3 mm Pepmap
C 18 material. Mobile phase A consisted of 0.1% formic acid in a by the manufacturer (Qiagen).
2% acetonitrile solution, while mobile phase B consisted of 0.1%
formic acid in an 80/20 acetonitrile/water solution. Peptides were Acknowledgments
eluted from the column into the microelectrospray ion source of the
Q-TOF using a gradient of 1% B to 40% B in 30 min. The outlet of The authors thank Karl Whitney for the gift of Crry in pcDNA3 expres-
the capillary column was coupled to a platinum-coated fused silica sion vector and for his helpful comments on the manuscript. The
spray tip (20 mm tip outlet, New Objective, Inc., Cambridge, MA) authors thank K. V. Rajagopalan for the gift of His-tagged sulfite
held in the Micromass capillary microelectrospray holder that sup- oxidase expression vector. This work was supported by a grant
plied 2–5 psi of air pressure to assist in nebulization. MS survey from the National Institute of Neurological Disorders and Stroke
scans were acquired at a rate of two per second from m/z 400–1800. (NS036808 to J. O. M.).
The instrument was operated in a data-dependent MS to MS/MS
switching mode where peptide ions detected in MS survey scans Received July 20, 2000; revised September 5, 2000.
triggered a switch to MS/MS for obtaining peptide product ion spec-
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